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of classical Hodgkin lymphoma identiﬁes key
regulators of disease susceptibility
Amit Sud et al.#
Correction to: Nature Communications; https://doi.org/10.1038/s41467-017-00320-1; published online 1 December 2017
The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-
Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and HTML
versions of the Article.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2019
Amit Sud 1, Hauke Thomsen 2, Philip J. Law 1, Asta Försti2,3, Miguel Inacio da Silva Filho2, Amy Holroyd1,
Peter Broderick 1, Giulia Orlando1, Oleg Lenive1, Lauren Wright1, Rosie Cooke1, Douglas Easton4,5,
Paul Pharoah 4,5, Alison Dunning4, Julian Peto6, Federico Canzian7, Rosalind Eeles 1,8, Zsoﬁa Kote-Jarai1,
Kenneth Muir 9,10, Nora Pashayan 5,11, The PRACTICAL consortiumPer Hoffmann12,13,
Markus M. Nöthen13,14, Karl-Heinz Jöckel15, Elke Pogge von Strandmann16, Tracy Lightfoot17, Eleanor Kane17,
Eve Roman17, Annette Lake18, Dorothy Montgomery18, Ruth F. Jarrett18, Anthony J. Swerdlow1,19,
Andreas Engert16, Nick Orr20, Kari Hemminki2,3 & Richard S. Houlston1,20
1Division of Genetics and Epidemiology, The Institute of Cancer Research, London SW7 3RP, UK. 2Division of Molecular Genetic Epidemiology,
German Cancer Research Centre, Heidelberg 69120, Germany. 3Centre for Primary Health Care Research, Lund University, Malmö 221 00, Sweden.
4Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. 5Centre for Cancer Genetic
Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. 6Department of Non-
Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. 7Genomic Epidemiology Group,
German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. 8Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. 9Institute of
Population Health, University of Manchester, Manchester M1 3BB, UK. 10Division of Health Sciences, Warwick Medical School, Warwick University,
https://doi.org/10.1038/s41467-018-08105-w OPEN
Correspondence and requests for materials should be addressed to R.S.H. (email: richard.houlston@icr.ac.uk). #A full list of authors and their afﬁliations
appears at the end of the paper.
NATURE COMMUNICATIONS |          (2019) 10:157 | https://doi.org/10.1038/s41467-018-08105-w |www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Warwick CV4 7AL, UK. 11Department of Applied Health Research, University College London, London WC1E 7HB, UK. 12Department of
Biomedicine, Division of Medical Genetics, University of Basel, Basel 4031, Switzerland. 13Institute of Human Genetics, University of Bonn, Bonn
53127, Germany. 14Department of Genomics, Life & Brain Center, University of Bonn, Bonn 53127, Germany. 15University of Duisburg–Essen, Essen
47057, Germany. 16Department of Internal Medicine, University Hospital of Cologne, Cologne 50937, Germany. 17Department of Health Sciences,
University of York, York YO10 5DD, UK. 18MRC University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. 19Division of Breast Cancer
Research, The Institute of Cancer Research, London SW7 3RP, UK. 20Division of Molecular Pathology, The Institute of Cancer Research, London
SW7 3RP, UK. These authors contributed equally: Amit Sud, Hauke Thomsen. These authors jointly supervised this work: Kari Hemminki, Richard S.
Houlston. A full list of consortium members appears at the end of the paper. The original article can be found online at https://doi.org/10.1038/
s41467-017-00320-1.
The PRACTICAL consortium
Brian E. Henderson21, Christopher A. Haiman21, Sara Benlloch1,5, Fredrick R. Schumacher22,23,
Ali Amin Al Olama5,24, Sonja I. Berndt25, David V. Conti21, Fredrik Wiklund26, Stephen Chanock25,
Victoria L. Stevens27, Catherine M. Tangen28, Jyotsna Batra29,30, Judith Clements29,30, Henrik Gronberg26,
Johanna Schleutker31,32,33, Demetrius Albanes25, Stephanie Weinstein25, Alicja Wolk34, Catharine West35,
Lorelei Mucci36, Géraldine Cancel-Tassin37,38, Stella Koutros25, Karina Dalsgaard Sorensen39,40,
Lovise Maehle41, David E. Neal42,43, Ruth C. Travis44, Robert J. Hamilton45, Sue Ann Ingles21,
Barry Rosenstein46,47, Yong-Jie Lu48, Graham G. Giles49,50, Adam S. Kibel51, Ana Vega52,
Manolis Kogevinas53,54,55,56, Kathryn L. Penney57, Jong Y. Park58, Janet L. Stanford59,60, Cezary Cybulski61,
Børge G. Nordestgaard62,63, Hermann Brenner64,65,66, Christiane Maier67, Jeri Kim68, Esther M. John69,70,
Manuel R. Teixeira71,72, Susan L. Neuhausen73, Kim De Ruyck74, Azad Razack75, Lisa F. Newcomb59,76,
Davor Lessel77, Radka Kaneva78, Nawaid Usmani79,80, Frank Claessens81, Paul A. Townsend82,
Manuela Gago-Dominguez83,84, Monique J. Roobol85 & Florence Menegaux86
21Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los
Angeles, CA 90033, USA. 22Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.
23Seidman Cancer Center, University Hospitals, Cleveland, OH 44106, USA. 24Department of Clinical Neurosciences, University of Cambridge,
Cambridge CB2 1TN, UK. 25Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
26Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden. 27Epidemiology Research Program,
American Cancer Society, 250 Williams Street, Atlanta, Georgia 30303, USA. 28SWOG Statistical Center, Fred Hutchinson Cancer Research
Center, Seattle, WA 98109, USA. 29Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of
Biomedical Science, Queensland University of Technology, Brisbane, QLD 4059, Australia. 30Translational Research Institute, Brisbane, QLD 4102,
Australia. 31Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, FI-20520 Turku, Finland. 32Tyks
Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, FI-20520 Turku, Finland. 33BioMediTech, University of
Tampere, Tampere 33100, Finland. 34Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet,, SE-171 77
Stockholm, Sweden. 35Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related
Research, The Christie Hospital NHS Foundation Trust, Manchester M13 9NT, UK. 36Department of Epidemiology, Harvard School of Public Health,
Boston, MA 02115, USA. 37CeRePP, Pitie-Salpetriere Hospital, 75013 Paris, France. 38UPMC Univ Paris 06, GRC N°5 ONCOTYPE-URO, CeRePP,
Tenon Hospital, 75020 Paris, France. 39Department of Molecular Medicine, Aarhus University Hospital, 8000 Aarhus C, Denmark. 40Department
of Clinical Medicine, Aarhus University, 8000 Aarhus C, Denmark. 41Department of Medical Genetics, Oslo University Hospital, N-0424 Oslo,
Norway. 42Department of Oncology, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, UK. 43Cancer Research UK,
Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK. 44Cancer Epidemiology, Nufﬁeld Department of Population Health,
University of Oxford, Oxford OX3 7LF, UK. 45Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
46Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. 47Department of Genetics and
Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. 48Centre for Molecular Oncology, Barts Cancer Institute,
Queen Mary University of London, John Vane Science Centre, London EC1M 6BQ, UK. 49Cancer Epidemiology Centre, The Cancer Council Victoria,
Melbourne, VIC 3004, Australia. 50Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of
Melbourne, Melbourne, VIC 3053, Australia. 51Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA 02115, USA. 52Fundación
Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, 15782 Santiago de Compostela, Spain. 53Centre for
Research in Environmental Epidemiology (CREAL), Barcelona Institute for Global Health (ISGlobal), 60803 Barcelona, Spain. 54CIBER Epidemiología
y Salud Pública (CIBERESP), 28029 Madrid, Spain. 55IMIM (Hospital del Mar Research Institute), 08003 Barcelona, Spain. 56Universitat Pompeu
Fabra (UPF), 08002 Barcelona, Spain. 57Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital/
Harvard Medical School, Boston, MA 02115, USA. 58Department of Cancer Epidemiology, Mofﬁtt Cancer Center, Tampa, FL 33612, USA. 59Division
of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. 60Department of Epidemiology, School of Public
Health, University of Washington, Seattle, WA 98195, USA. 61International Hereditary Cancer Center, Department of Genetics and Pathology,
Pomeranian Medical University, 70-001 Szczecin, Poland. 62Faculty of Health and Medical Sciences, University of Copenhagen, 1165 Copenhagen,
Denmark. 63Department of Clinical Biochemistry, Herlev and Gentofte Hospital, University Hospital, 2900 Copenhagen, Denmark. 64Division of
Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. 65German Cancer Consortium
(DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. 66Division of Preventive Oncology, German Cancer Research
Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany. 67Institute for Human Genetics, University Hospital
AUTHOR CORRECTION NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08105-w
2 NATURE COMMUNICATIONS |          (2019) 10:157 | https://doi.org/10.1038/s41467-018-08105-w |www.nature.com/naturecommunications
Ulm, 89081 Ulm, Germany. 68Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston,
TX 77030, USA. 69Cancer Prevention Institute of California, Fremont, CA 94538, USA. 70Department of Health Research & Policy (Epidemiology)
and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA. 71Department of Genetics, Portuguese Oncology
Institute of Porto, 4200-072 Porto, Portugal. 72Biomedical Sciences Institute (ICBAS), University of Porto, 4200-072 Porto, Portugal. 73Department
of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA 91016, USA. 74Faculty of Medicine and Health Sciences, Basic
Medical Sciences, Ghent University, 9000 Ghent, Belgium. 75Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala
Lumpur, Malaysia. 76Department of Urology, University of Washington, Seattle, WA 98105, USA. 77Institute of Human Genetics, University
Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. 78Molecular Medicine Center, Department of Medical Chemistry and
Biochemistry, Medical University, 1431 Soﬁa, Bulgaria. 79Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G
2R3, Canada. 80Division of Radiation Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada. 81Molecular Endocrinology Laboratory,
Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium. 82Institute of Cancer Sciences, Manchester Cancer Research
Centre, University of Manchester, Manchester Academic Health Science Centre, St Mary’s Hospital, Manchester M13 9WL, UK. 83Genomic
Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo
Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, 15706 Santiago De Compostela, Spain. 84University of California San
Diego, Moores Cancer Center, La Jolla, CA 92093, USA. 85Department of Urology, Erasmus University Medical Center, 3015 CE Rotterdam, The
Netherlands. 86Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud,
University Paris-Saclay, F-94805 Villejuif, France
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08105-w AUTHOR CORRECTION
NATURE COMMUNICATIONS |          (2019) 10:157 | https://doi.org/10.1038/s41467-018-08105-w |www.nature.com/naturecommunications 3
